United States · 
Who invested in Aptus Endosystems?
Aptus Endosystems's investors include U.S. Venture Partners, Longitude Capital and Synergy Life Science Partner.
20112012
$15MSeries A$25MSeries BUnited States · Series B startup
Who invested in Aptus Endosystems
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$40Mraised across 2 rounds since 2010, from 2 sources
$15MSeries A$25MSeries B
- Latest round
- Series B, $25MJun 2012
- Step-upi
- 1.7×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $15M Aug 2010
- Biggest round
- $25M Series B · Jun 2012
- Between rounds
- 22 months from the last two
The rounds
- Jun 2012Series B$25M1 new2 returning
Reported by finance.yahoo.com
- Aug 2010
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Synergy Life Science PartnerGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Aptus Endosystems
How much has Aptus Endosystems raised?
Aptus Endosystems has raised $40M across 2 rounds since 2010.
When did Aptus Endosystems last raise?
Aptus Endosystems's most recent round was a Series B of $25M in Jun 2012.
What was Aptus Endosystems's biggest round?
Its most recent round, $25M in Jun 2012, is also its largest on record.
Who backed Aptus Endosystems first?
Aptus Endosystems's first round on record, in Aug 2010, was backed by U.S. Venture Partners and Longitude Capital.
What stage is Aptus Endosystems at?
Aptus Endosystems's latest named round is a Series B, in Jun 2012.
Where is Aptus Endosystems based?
Aptus Endosystems is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.